Developmental Powered Mobility for Cerebral Palsy
(DRIVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to understand the effects of developmental powered mobility intervention on global development, gross motor function, and activity performance outcomes in 48 young children (ages 1-2 years) with cerebral palsy (CP). The main question it aims to answer is:
Does the developmental powered mobility intervention produce greater improvements in global development and activity performance outcomes in young children with CP?
How will the developmental powered mobility intervention effect gross motor function?
Researchers will compare the developmental powered mobility (DPM) intervention to usual care physical therapy focused on movement, orientation, repetition, and exercise (MORE-PT) to see if DPM produces greater improvements in outcomes without impeding gross motor function.
Child Participants will:
Receive either DPM or MORE-PT twice weekly for 12 weeks in the home setting.
Complete assessments with the interventionist before and after the 12-week intervention and at a 6-month follow-up visit.
Caregiver participants will: Track outside therapies and any outside assistive device use completed during the intervention, in a weekly log.
Who Is on the Research Team?
Heather Feldner, PhD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for young children aged 1-2 years diagnosed with cerebral palsy or similar nervous system disorders. Participants should be able to take part in home-based therapy sessions and have a caregiver who can help track their progress.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Developmental Powered Mobility Intervention (DPM)
Trial Overview
The study compares two types of therapy: one group uses a powered mobility device (Permobil Explorer Mini) designed for young kids, while the other receives standard physical therapy focused on movement and exercise. Both groups get therapy twice weekly at home for 12 weeks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Children randomized to this group will engage in home-based DPM activities using the Explorer Mini device, focusing on three main areas: tool use, exploratory perceptual motor experiences, and goal directed mobility.
Children randomized to this group will engage in a home-based usual care physical therapy intervention, focusing on movement, orientation, repetition, and exercise-physical therapy.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.